Loading clinical trials...
Loading clinical trials...
MK0869 and MK0517 Time-on-Target PET Study
Conditions
Interventions
Fosaprepitant 150 mg
Aprepitant 165 mg
+5 more
Start Date
April 1, 2010
Primary Completion Date
October 1, 2010
Completion Date
October 1, 2010
Last Updated
February 25, 2015
NCT04472143
NCT00952341
Lead Sponsor
Merck Sharp & Dohme LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions